Marc David Benathen

Marc David Benathen, listed as finance chief, appears in our data through filings on LifeMD, Inc. shares, published by SEC (Form 4). The record holds 10 filings, for trades running from 19 May 2021 to 22 August 2025.

In open-market terms, that means 3 purchases worth €44k on one side and 1 sale worth €850k on the other. Netting one side against the other leaves €806k of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 4 share grants and 2 option exercises. 2025 to date brings no purchases and 1 sale.

In size, the median ticket on the buying side is €8,065. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The record was last updated on 26 August 2025 with a share grant in LifeMD, Inc. The clock since the last published purchase (1 December 2021) now reads 1,782 days. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.